Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avid Bioservices Inc CDMO

Healthcare Biotechnology
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing of biologics for the biotechnology and biopharmaceutical industries. It operates in a single segment, which is contract manufacturing and development services... see more

Recent & Breaking News (NDAQ:CDMO)

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2022 and Recent Developments

GlobeNewswire December 6, 2022

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022

GlobeNewswire November 29, 2022

Avid Bioservices Appoints Oksana Lukash as Vice President, People

GlobeNewswire November 16, 2022

Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference

GlobeNewswire November 2, 2022

TOMI to Install Custom Engineered Integrated iHP System in Avid Bioservices, Inc. Viral Vector Manufacturing Facility in California

GlobeNewswire October 10, 2022

Avid Bioservices to Participate in RBC Global CDMO Conference

GlobeNewswire September 27, 2022

Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations

GlobeNewswire September 22, 2022

Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Conference

GlobeNewswire September 7, 2022

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments

GlobeNewswire September 6, 2022

Avid Bioservices Appoints Pramthesh (Prem) Patel, Ph.D., as Vice President, Process Development for Mammalian Cell Business

GlobeNewswire September 1, 2022

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2023 After Market Close on September 6, 2022

GlobeNewswire August 30, 2022

Avid Bioservices Reports Financial Results for Fourth Quarter and Full Fiscal Year Ended April 30, 2022 and Recent Developments

GlobeNewswire June 29, 2022

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2022 After Market Close on June 29, 2022

GlobeNewswire June 22, 2022

Avid Bioservices, Inc. and CRB highlight efforts that enabled opening of first phase of new viral vector facility in California in only eight months

PR Newswire June 16, 2022

Avid Bioservices Announces Launch of Analytical and Process Development Suites Within New, World-Class Viral Vector Development and Manufacturing Facility

GlobeNewswire June 14, 2022

Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business

GlobeNewswire June 13, 2022

Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Forum

GlobeNewswire March 16, 2022

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2022 and Recent Developments

GlobeNewswire March 8, 2022

Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2022 after Market Close on March 8, 2022

GlobeNewswire March 1, 2022

Avid Bioservices Announces Official Opening of Second Downstream Processing Suite Within Myford North Facility

GlobeNewswire January 10, 2022